A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignancies.
Autor: | How, Joan, Ren, Siyang, Lombardi‐Story, Jennifer, Bergeron, Meghan, Foster, Julia, Amrein, Phillip C., Brunner, Andrew M., Fathi, Amir T., Hock, Hanno, Khachatryan, Anna, Kikuchi, Hiroto, Ng, Mei Rosa, Moran, Jenna, Narayan, Rupa, Neuberg, Donna, Ramos, Aura, Som, Tina, Vartanian, Meghan, Chen, Yi‐Bin, Duda, Dan G. |
---|---|
Zdroj: | EJHaem; May2022, Vol. 3 Issue 2, p434-442, 9p |
Databáze: | Complementary Index |
Externí odkaz: |